| NCT ID | NCT07081945 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Eye & ENT Hospital of Fudan University |
| Condition | Rhegmatogenous Retinal Detachment |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-08-01 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-08-01 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of the study is to evaluate the efficacy of using hAM patches over the retina to seal inferior retinal breaks. The researchers will evaluate whether hAM patch-assisted vitrectomy improves surgical success rate of retinal reattachment.
Eligibility Criteria
Inclusion Criteria: 1. Subjects having given free and informed consent to take part in the study. 2. Subjects between 18 and 70 years old. 3. Subjects suffering RRD (both primary and recurrent RRDs) with at least one of these conditions: 1. inferior retinal breaks between 4- and 8-o'clock within the detached area regardless of PVR grade; 2. requiring retinotomy inferiorly between 4- and 8-o'clock (due to severe inferior PVR or inferior retinal shortening). Exclusion Criteria: 1. Subjects with RRD with only anterior retina breaks or dialysis and meet the indications for scleral buckling surgery. 2. Subjects with RRD whose retinal breaks located between the 4- and 8-o'clock positions and are not involved in the detached area. 3. Subjects with pre-existing serious eye diseases (corneal ulcers, glaucoma, uveitis, etc). 4. History of epilepsy or serious psychiatric diseases. 5. Other conditions that the researcher found improper to be included into this study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07081945 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Rhegmatogenous Retinal Detachment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07081945 currently recruiting?
Yes, NCT07081945 is actively recruiting participants. Contact the research team at zhongcui.sun@aliyun.com for enrollment information.
Where is the NCT07081945 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT07081945 clinical trial?
NCT07081945 is sponsored by Eye & ENT Hospital of Fudan University. The trial plans to enroll 50 participants.